BANGALORE, India, October 5, 2022 /PRNewswire/ — An estimated 18.1 million people worldwide will be diagnosed with cancer in 2021, according to the World Health Organization (WHO). – Obviously, even the most advanced treatments are not enough to stop this deadly disease once it has metastasized and spread throughout the body. Fortunately, there may be a cure closer than you think – and OncoDynamiX is leading the way with its new technology platform for personalized cancer treatment to improve medical outcomes and reduce treatment costs.
OncoDynamiX providing tailor-made treatments and advanced technologies for the treatment of cancer.
Cancer is curable! OncoDynamiX represents an important step towards a future without death because cancer can be treated if someone seeks help early enough. The goal is to help patients around the world South East Asia, Africaand Latin America for information on cancer screening, survival rates for different cancers, diagnostic advice, and more.
Critical points of the ONCODYNAMIX platform to help cancer patients
OncoDynamiX uses two platforms to target cancer treatment.
NEOTOX is a novel data-driven methodology for pragmatic precision medicine, which is a non-NGS pathway to personalized cancer therapy. The technology predicts a cancer patient’s clinical outcome to a specific drug-specific cancer or drug combination and validates in a 3D lab environment before summarizing to each patient.
ONCEMBLEX, which is a genomics-driven methodology for precision medicine in cancer. The workflow uses state-of-the-art protocols in NGS for an exhaustive set of cancer-relevant genes – whether known, targetable signatures or drivers and passengers of unknown significance. This technology allows us to identify the best drug or combination of drugs with maximum therapeutic benefit.
OncoDynamiX is a global precision cancer treatment solutions company headquartered in Bengaluru, India operating since 2020 with more than 50 man-years of research, 15 million cancer data points and 1500 cancer cell lines, 250 cancer drugs with NeoTox and Oncemblex platforms to give personalized therapy. Mr. Sundaresh Babuthe CEO of OncoDynamiXsaid, “The goal of both platforms is to provide personalized cancer treatment to patients, improve their lifestyle, reduce the cost of treatment and save lives. In addition, this partnership brings the solution closer to the rest of the world.
George Molakal, Global Director at OncoDynamiX spoke at the health conference in Chicago about OncoDynamiX. He said it is revolutionary in cancer treatment and shows hope for cancer patients to get the right drugs. It’s no secret that cancer treatments can be expensive. And not just financially, but they also pose significant health concerns. This is where OncoDynamix comes in and promises to provide patients with a platform where they can get all the information they need about curative cancer treatment at affordable rates. This ensures that no one has a hard time fighting cancer.
SOURCEOncoDynamiX
